Form 4 for EYPT EyePoint, Inc.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001562180-24-001293 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-13 | 2024-02-09 | EYPT | Paggiarino Dario A. | Chief Medical Off | F - Tax | $28.80 | -5,083 | 42.2K | -11% | -$146.4K |
| DM | 2024-02-13 | 2024-02-09 | EYPT | Paggiarino Dario A. | Chief Medical Off | M - OptEx | $0.00 | +10.8K | 41.5K | +35% | $0 |
| DM | 2024-02-13 | 2024-02-09 | EYPT | Paggiarino Dario A. | Chief Medical Off | M - OptEx | $0.00 | -10.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-09 | F | D | 2,518 | $28.80 | 44,787 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-09 | F | D | 2,565 | $28.80 | 42,222 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-09 | M | A | 5,833 | $0.00 | 47,305 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-09 | M | A | 4,967 | $0.00 | 41,472 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2024-02-09 | M | D | 5,833 | $0.00 | 5,834 | D | $0.00 · — to 2032-02-09 | 5,833 Common Stock | (F3) The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. |
| 6 | Derivative | Restricted Stock Units | 2024-02-09 | M | D | 4,967 | $0.00 | 0 | D | $0.00 · — to 2031-02-09 | 4,967 Common Stock | (F2) The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. |